International Journal of Clinical Pharmacy

, Volume 33, Issue 2, pp 177–182 | Cite as

Community pharmacy compounding–impact on professional status

  • Jennifer Anne GiamEmail author
  • Andrew J. McLachlan
  • Ines Krass
Review Article


Aim of the Review Extemporaneous compounding has been a core function for pharmacists and was the basis of pharmacy’s claim to professional status. The re-emergence of compounding as a specialised practice warrants investigation regarding the influence of this practice on pharmacy’s professional status. The aim of this study was to investigate the contribution of extemporaneous compounding to the professional status of pharmacists in community practice. Method A search of the literature was conducted using MEDLINE, EMBASE, IPA, ISI WEB OF KNOWLEDGE, PROQUEST SOCIAL SCIENCE JOURNALS, JSTOR and SOCIOLOGICAL ABSTRACTS databases to identify relevant original research articles, reviews or commentaries. Results Compounding was an important part of pharmacy’s claim to professional status. The expansion of the pharmaceutical industry and decline in demand for compounded medications led to a view that pharmacy suffered a loss of professional status. In recent decades patient centred services have been introduced as a reprofessionalisation strategy. Evidence suggests that compounding, as a specialty practice based on a patient centred approach, is increasingly provided in Australia and the United States. Conclusion Compounding has emerged as a specialised area of pharmacy practice in Australia and the United States, and when practiced as a patient centred activity may be a strategy for reprofessionalisation. The extension of compounding beyond mere supply and distribution of a pharmaceutical product to become a platform for development of collaborative professional relationships may also lead to enhanced professional status of pharmacists.


Compounding Extemporaneous Pharmaceutical care Profession Professionalisation Specialisation 


Conflicts of interest



  1. 1.
    Giam JA, McLachlan AJ. Extemporaneous product use in paediatric patients: a systematic review. Int J Pharm Pract. 2008;16:1–8.CrossRefGoogle Scholar
  2. 2.
    United States Pharmacopeial Convention. < 795 > Pharmacy Compounding. The United States Pharmacopeia 33 and National Formulary 28. Rockville, MD: United States Pharmacopeial Convention, Inc; 2010.Google Scholar
  3. 3.
    Slezak M. The roots of modern pharmacy practice. Am Drug. 1996;213:32–64.Google Scholar
  4. 4.
    Morgall JM, Almarsdóttir AB. No struggle, no strength: how pharmacists lost their monopoly. Soc Sci Med. 1999;48:1247–58.PubMedCrossRefGoogle Scholar
  5. 5.
    Savage DA. The professions in theory and history: the case of pharmacy. Bus Econ Hist. 1994;23:129–59.Google Scholar
  6. 6.
    Traulsen JM, Bissell P. Theories of the professions and the pharmacist. Int J Pharm Pract. 2004;12:107–14.CrossRefGoogle Scholar
  7. 7.
    Southon G, Braithwaite J. The end of professionalism? Soc Sci Med. 1998;46:23–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Hofoss D. Health professions—the origin of species. Soc Sci Med. 1986;22:201–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Hammer DP, Berger BA, Beardsley RS, Easton MR. Student professionalism. Am J Pharm Educ. 2003;67:Article 96. Available at
  10. 10.
    Hammer DP. Professional attitudes and behaviors: the “A’s and B’s” of professionalism. Am J Pharm Educ. 2000;64:455–64.Google Scholar
  11. 11.
    Dingwall R, Wilson E. Is pharmacy really an ‘incomplete’ profession. Perspect Socl Prob. 1995;7:111–28.Google Scholar
  12. 12.
    Cruess SR, Johnston S, Cruess RL. Professionalism for medicine: opportunities and obligations. Med J Aust. 2002;177:208–11.PubMedGoogle Scholar
  13. 13.
    Carr-Saunders AM, Wilson PA. The professions. 1st ed. Oxford: Clarendon Press; 1933. ISBN.Google Scholar
  14. 14.
    Caldwell I. What does it mean to be a member of a profession in 21st century Britain? Pharm J. 2007;278:461–2.Google Scholar
  15. 15.
    American Pharmaceutical Association Academy of Students of Pharmacy, American Association of Colleges of Pharmacy Council of Deans Task Force on Professionalism. White paper on pharmacy student professionalism. J Am Pharm Assoc (Wash). 2000;40:96–100.Google Scholar
  16. 16.
    van Mook WN, de Grave WS, Wass V, O’Sullivan H, Zwaveling JH, Schuwirth LW, et al. Professionalism: evolution of the concept. Eur J Intern Med. 2009;20:e81–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Freidson E. Professionalism reborn—theory, prophecy and policy. Cambridge: Polity Press; 1994. ISBN 0745614469.Google Scholar
  18. 18.
    Freidson E. Profession of medicine: a study of the sociology of applied knowledge. New York: Harper & Row; 1970. ISBN 006042205X.Google Scholar
  19. 19.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practioners in the United Kingdom. Soc Sci Med. 2001;53:943–55.PubMedCrossRefGoogle Scholar
  20. 20.
    Gilbert AL. What will it take for pharmacy practice to change? J Pharm Pract Res. 2009;39:4–5.Google Scholar
  21. 21.
    Ruston A. Achieving re-professionalisation: factors that influence the adoption of an ‘extended role’ by community pharmacists. A national survey. J Soc Adm Pharm. 2001;18:103–10.Google Scholar
  22. 22.
    White EV, Latif DA. Office based pharmacy practice—past, present and future. Ann Pharmacother. 2006;40:1409–14.PubMedCrossRefGoogle Scholar
  23. 23.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–41.PubMedGoogle Scholar
  24. 24.
    National Coordinating Committee on Therapeutic Goods. A discussion paper on regulation of extemporaneously prepared medicines in non-hospital pharmacies. Canberra 2008 [Cited 2008 14 April]; Available from:
  25. 25.
    Committee on health education labor and pensions. Federal and State role in pharmacy compounding and reconstitution: Exploring the right mix to protect patients. Senate Committee on Health, Education, Labor, and Pensions. Washington DC: US Government Printing Office; 2003.Google Scholar
  26. 26.
    Holland R, Nimmo C. Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm. 1999;56:1758–64.PubMedGoogle Scholar
  27. 27.
    Harding G, Taylor K. Responding to change: the case of community pharmacy in Great Britain. Sociol Health Illn. 1997;19:547–60.Google Scholar
  28. 28.
    Fischelis RP. Pharmacy’s unfinished tasks. Science. 1935;81:301–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Mullarkey T. Pharmacy compounding of high-risk level products and patient safety. Am J Health Syst Pharm. 2009;66:S4–13.PubMedCrossRefGoogle Scholar
  30. 30.
    Thorner I. Pharmacy: the functional significance of an institutional pattern. Soc Forces. 1942;20:321–8.CrossRefGoogle Scholar
  31. 31.
    Clouse EH. Is extemporaneous compounding still an indication of pharmacist’s professionalism? Tennessee Pharma. 1986;22:14–5.Google Scholar
  32. 32.
    Eaton G, Webb B. Boundary encroachment: pharmacists in the clinical setting. Sociol Health Illn. 1979;1:69–89.PubMedCrossRefGoogle Scholar
  33. 33.
    Denzin NK, Mettlin CJ. Incomplete professionalization: the case of pharmacy. Soc Forces. 1968;46:375–81.CrossRefGoogle Scholar
  34. 34.
    Knapp DA, Knapp DE. An appraisal of the contemporary practice of pharmacy. Am J Pharm Educ. 1968;32:747–58.Google Scholar
  35. 35.
    Turner BS. Medical power and social knowledge. 2nd ed. London: Sage Publications; 1995. ISBN 0803975988.Google Scholar
  36. 36.
    Zacker C, Mucha L. Institutional and contingency approaches to the reprofessionalization of pharmacy. Am J Health Syst Pharm. 1998;55:1302–5.PubMedGoogle Scholar
  37. 37.
    Young TJ, Pritchard KW. Sociological analysis of pharmacy as a quasi-profession. Free Inq Creat Sociol. 1985;13:63–6.Google Scholar
  38. 38.
    Dickson WM, Rodowskas CA. Verbal communications of community pharmacists. Med Care. 1975;13:486–98.PubMedCrossRefGoogle Scholar
  39. 39.
    Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med. 1982;16:871–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Tanner J, Cockerill R, Barnsley J, Williams A. Gender and clinical pharmacy: the career of an occupational ideology. Can Rev Sociol Anthropol. 1998;35:535–51.CrossRefGoogle Scholar
  41. 41.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharamcists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600–6.PubMedGoogle Scholar
  42. 42.
    Bissell P. Social capital and community pharmacy: a critical review. Eur J Soc Qual. 2006;6:109–19.CrossRefGoogle Scholar
  43. 43.
    Gilbert L. Pharmacy’s attempts to extend its roles: a case study in South Africa. Soc Sci Med. 1998;47:153–64.PubMedCrossRefGoogle Scholar
  44. 44.
    Penna RP. Pharmacy: a profession in transition or a transitory profession? Am J Hosp Pharm. 1987;44:2053–9.PubMedGoogle Scholar
  45. 45.
    Rossing C, Hansen E, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Admin Pharm. 2001;19:55–64.Google Scholar
  46. 46.
    Miller MJ, Ortmeier BG. Factors influencing the delivery of pharmacy services. Am Pharm. 1995;NS35:39–45.PubMedGoogle Scholar
  47. 47.
    Tully MP, Seston EM, Cantrill JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Pract. 2000;8:188–97.CrossRefGoogle Scholar
  48. 48.
    Doucette W, Kreling D, Schommer J, Gaither C, Mott D, Pedersen C. Evaluation of community pharmacy service mix: evidence from the 2004 national pharmacist workforce study. J Am Pharm Assoc (2003). 2006; 46:348–55.Google Scholar
  49. 49.
    National Community Pharmacists Association. Resilient community pharmacies rely on patient services to weather economic downturn, competition, According to 2009 NCPA Digest. 2009 [Cited 2010 4 February]; Available from:
  50. 50.
    Harding G, Taylor K. Extemporaneous preparation teaching in the UK schools of pharmacy: anachronism or badge of office? Pharm Educ. 2005;5:183–8.CrossRefGoogle Scholar
  51. 51.
    Federal and State role in pharmacy compounding and reconstitution: Exploring the right mix to protect patients: Senate Committee on Health, Education, Labor, and Pensions, United States Senate (October 23, 2003).Google Scholar
  52. 52.
    McPherson TB, Fontane PE. Patient-centered care in the community-based compounding practice setting J Am Pharm Assoc (2003). 2010;50:37-44.Google Scholar
  53. 53.
    Pappas A. Extemporaneous dispensing: opinions of Victorian community pharmacists. Aust J Hosp Pharm. 1999;29:196–201.Google Scholar
  54. 54.
    Greenberg AR, Barnett CW. Metro Atlanta Board specialists attitudes toward compounding pharmacy. Int J Pharm Compd. 2004;8:65–72.Google Scholar
  55. 55.
    Underhill LA, Campbell NA, Rhodes CT. Regulatory and clinical aspects of the resurgence of compounding by pharmacists. Drug Dev Ind Pharm. 1996;22:659–66.CrossRefGoogle Scholar
  56. 56.
    Humphrys P, O’Brien GE. The relationship between skill utilization, professional orientation and job satisfaction for pharmacists. J Occup Psychol. 1986;59:315–26.Google Scholar
  57. 57.
    Taylor KMG, Harding G, Bissenden B, Shepherd O, Shooter B. “It Made Me Feel Like a Pharmacist, Not Just a Science Student”: pharmacy undergraduates attitudes towards extemporaneous dispensing practical classes. Pharm Educ. 2004;4:137–42.CrossRefGoogle Scholar
  58. 58.
    Letendre W, Shepherd M, Brown C. Comparison of job satisfaction for compounders and non compounders. Int J Pharm Compd. 1998;2:455–62.Google Scholar
  59. 59.
    United States Pharmacopeial Convention. < 1075 > Good compounding practices The United States Pharmacopeia 28 and National Formulary 23. Rockville, MD: United States Pharmacopeial Convention, Inc; 2004.Google Scholar
  60. 60.
    McPherson T, Fontane P, Jackson K, Martin K, Berry T, Chereson R, et al. Prevalence of compounding in independent community pharmacy practice. J Am Pharm Assoc (2003). 2006;46:568-73.Google Scholar
  61. 61.
    Berbatis C, Sunderland V, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s national pharmacy database project. Int J Pharm Pract. 2007;15:185–91.CrossRefGoogle Scholar
  62. 62.
    Dunphy D, Palmer I, Benrimoj SI, Roberts A. Final report - the shape of our future, change management and community pharmacy project. 2005 [Cited 2005 April 11]; Available from:
  63. 63.
    Giam JA, McLachlan AJ, Krass I. Specialised compounding - practices and opinions of Australian community pharmacists. J Pharm Pract Res. 2007;37:260–4.Google Scholar
  64. 64.
    Berbatis C, Sunderland VB, Mills C, Bulsara M. National pharmacy database project. Perth: School of Pharmacy, Curtin University of Technology of Western Australia; 2003 [Cited 2005 June 17]; Available from:
  65. 65.
    Giam J, McLachlan A, Krass I. Specialized compounding in community pharmacies: Organizational perspective. J Am Pharm Assoc (2003). 2010;50:354-61.Google Scholar
  66. 66.
    Stolar MH. The decline and fall of secundem artem. Am J Hosp Pharm. 1979;36:1053.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Jennifer Anne Giam
    • 1
    Email author
  • Andrew J. McLachlan
    • 1
    • 2
  • Ines Krass
    • 1
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia
  2. 2.Concord Hospital Centre for Education and Research on AgeingConcord RG HospitalConcordAustralia

Personalised recommendations